# NMN (Nicotinamide Mononucleotide)

> Nicotinamide mononucleotide (NMN) is a naturally occurring nucleotide that acts as a direct precursor in the body's synthesis of NAD+. It has drawn substantial research and consumer interest as an oral supplement for metabolic health and age-related decline, and more recently as a subcutaneous injectable for those seeking to bypass gut metabolism. A handful of human trials have examined its effects on insulin sensitivity, vascular function, and physical performance, with mixed and generally modest results to date. It is one of the most widely marketed NAD+ precursors alongside nicotinamide riboside (NR), though the two are processed through different pathways. Long-term safety and optimal dosing in humans remain areas of active investigation.

- URL: https://www.lifeconverted.com/peptides/nmn
- Also known as: Nicotinamide Mononucleotide
- Primary category: Metabolic
- Effectiveness rank: #9 in Metabolic
- Evidence level: Moderate evidence
- Route: Subcutaneous (Oral and sublingual capsules are the most common consumer form; subcutaneous injection is used in some protocols to bypass first-pass gut metabolism.)
- Dose range: 125-500 mg
- Dose tiers: low 125 mg; moderate 250 mg; high 500 mg
- Half-life: Short plasma half-life, well under an hour; intracellular NAD+ elevation is more prolonged.
- Timing: Morning
- Cycle: Continuous or 8-12 week blocks on, 1-2 weeks off (Many users take NMN continuously; periodic breaks are sometimes suggested but are not established as necessary.)
- Storage: Store lyophilized powder frozen; refrigerate reconstituted solution and use within days to a few weeks.

## Mechanism of action

NMN is converted toward NAD+ through the nicotinamide riboside kinase pathway after being processed into nicotinamide riboside or taken up via dedicated transporters. Once inside cells, it feeds the NAD+ salvage pathway, supporting enzymatic reactions that depend on NAD+ as a cofactor, including sirtuins linked to metabolic regulation. Increasing substrate availability in this way is hypothesized to help offset age-related decline in NAD+ synthesis, though direct evidence in humans is still emerging.

## Reported benefits

- Studied for potential support of insulin sensitivity in early human trials
- Explored for vascular and cardiovascular metabolic markers
- Investigated for exercise-related endurance outcomes
- Proposed support for general cellular energy metabolism

## Reported side effects

- Generally reported as well tolerated at studied oral doses
- Mild nausea or gastrointestinal upset in some users
- Injection-site reactions with subcutaneous administration
- Long-term human safety data remain limited

## Common protocols

- Daily oral or subcutaneous dosing in longevity-focused stacks
- Cycled use alongside periodic NAD+ IV or injection sessions

## Stacking notes

Commonly combined with resveratrol, NAD+ infusions, or other longevity-focused compounds; interactions are not well studied.

---

Educational information only, not medical advice. Full disclaimer: https://www.lifeconverted.com/disclaimer